The State of Georgia now requires pharmacies that engage in compounding drugs for Office Use to be licensed with the FDA as such.

The Georgia Drugs & Narcotics Agency recently issued a statement noting the requirement that all state-licensed pharmacies that engage in compounding drugs for Office Use must be registered with the FDA as a 503(b) compounding entity. Whereas previous Georgia law allowed for the compounding of drugs for Office Use without a license, the State is now enforcing federal regulations governing the matter.

Information regarding 503(b) Compounding Facilities is available on the FDA website.